Boston Scientific, which is growing in Minnesota, is buying California’s Penumbra for $14.5 billion. CEO Mike Mahoney said the deal makes his company a neurovascular leader.
Ramstad: Picking up what’s left of UCare is the biggest gamble Medica has ever taken
The nonprofit health insurance company is betting a diverse set of products will help it steer through a time of immense turmoil in the industry.
AuthoredEvan Ramstad
December 22, 2025


